Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rick E. Winningham currently holds 9,567 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rick E. Winningham has been a net seller of TBPH stock. They have purchased $1.4M and sold $38.8M worth of shares.
Rick E. Winningham's most recent insider trade was on May 22, 2026, when they sold 3,415 shares at $0.00 per share.
Rick E. Winningham serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 180 insider transactions totaling $40.2M over their tenure at the company.
Rick E. Winningham holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Rick E. Winningham has shown a selling trading pattern, with $1.4M in total purchases and $38.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rick E. Winningham was on Feb 20, 2021, when they sold $2.1M worth of TBPH shares. This transaction involved 110,348 shares at $18.79 per share.
Rick E. Winningham currently owns 9,567 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rick E. Winningham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rick E. Winningham has 180 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Rick E. Winningham and 40,000+ other insiders.